Literature DB >> 22460993

Bone disease in primary hypercalciuria.

Stefania Sella1, Catia Cattelan, Giuseppe Realdi, Sandro Giannini.   

Abstract

Primary Hypercalciuria (PH) is very often accompanied with some degrees of bone demineralization. The most frequent clinical condition in which this association has been observed is calcium nephrolithiasis. In patients affected by this disorder bone density is very frequently low and increased susceptibility to fragility fractures is reported. The very poor definition of this bone disease from a histomorphometric point of view is a crucial aspect. At present, the most common finding seems to be a low bone turnover condition. Many factors are involved in the complex relationships between bone loss and PH. Since bone loss was mainly reported in patients with fasting hypercalciuria, a primary alteration in bone metabolism was proposed as a cause of both hypercalciuria and bone demineralization. This hypothesis was strengthened by the observation that some bone resorbing-cytokines, such as IL-1, IL-6, and TNF-α are high in hypercalciuric patients. The effect of an excessive response to the acid load induced by dietary protein intake seems an additional factor explaining a primitive alteration of bone. The intestine plays a major role in the clinical course of bone disease in PH. Patients with absorptive hypercalciuria less frequently show bone disease and a reduction in dietary calcium greatly increases the probability of bone loss in PH subjects. It has recently been reported that greater bone loss is associated with a larger increase in intestinal calcium absorption in PH patients. Considering the absence of PTH alterations, it was proposed that this is not a compensatory phenomenon, but probably the marker of disturbed cell calcium transport, involving both intestinal and bone tissues. While renal hypercalciuria is rather uncommon, the kidney still seems to play a role in the pathogenesis of bone loss of PH patients, possibly via the effect of mild to moderate urinary phosphate loss with secondary hypophosphatemia. In conclusion, bone loss is very common in PH patients. Even if most of the factors involved in this process have been identified, many aspects of this intriguing clinical condition remain to be elucidated.

Entities:  

Year:  2008        PMID: 22460993      PMCID: PMC2781204     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  73 in total

1.  Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.

Authors:  John R Asplin; Kimberly A Bauer; Jennifer Kinder; Georg Müller; Brian J Coe; Joan H Parks; Fredric L Coe
Journal:  Kidney Int       Date:  2003-02       Impact factor: 10.612

2.  The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin.

Authors:  A HODGKINSON; L N PYRAH
Journal:  Br J Surg       Date:  1958-07       Impact factor: 6.939

3.  Vertebral mineral content in diet-dependent and diet-independent hypercalciuria.

Authors:  L Borghi; T Meschi; A Guerra; L Maninetti; M Pedrazzoni; A Marcato; P Vescovi; A Novarini
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

4.  "Idiopathic" hypercalciuria and hereditary hypophosphatemic rickets. Two phenotypical expressions of a common genetic defect.

Authors:  M Tieder; D Modai; U Shaked; R Samuel; R Arie; A Halabe; J Maor; J Weissgarten; Z Averbukh; N Cohen
Journal:  N Engl J Med       Date:  1987-01-15       Impact factor: 91.245

5.  Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

Authors:  A E Broadus; K L Insogna; R Lang; A F Ellison; B E Dreyer
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

6.  Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria.

Authors:  A Ghazali; V Fuentès; C Desaint; P Bataille; A Westeel; M Brazier; L Prin; A Fournier
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

7.  Bone involvement in idiopathic hypercalciuria.

Authors:  A M Misael da Silva; L M dos Reis; R C Pereira; E Futata; C T Branco-Martins; I L Noronha; B L Wajchemberg; V Jorgetti
Journal:  Clin Nephrol       Date:  2002-03       Impact factor: 0.975

8.  Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones.

Authors:  W C Chen; H C Wu; H Y Chen; M C Wu; C D Hsu; F J Tsai
Journal:  Urol Res       Date:  2001-10

9.  Bone density and skeletal metabolism are altered in idiopathic hypercalciuria.

Authors:  S Giannini; M Nobile; L Sartori; L Calò; A Tasca; L Dalle Carbonare; M Ciuffreda; A D'Angelo; F Pagano; G Crepaldi
Journal:  Clin Nephrol       Date:  1998-08       Impact factor: 0.975

10.  Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density.

Authors:  H A Deutschmann; M Weger; W Weger; P Kotanko; M J Deutschmann; F Skrabal
Journal:  J Intern Med       Date:  2002-11       Impact factor: 8.989

View more
  9 in total

1.  Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study.

Authors:  S-M Ou; Y-T Chen; C-J Shih; D-C Tarng
Journal:  Osteoporos Int       Date:  2014-12-19       Impact factor: 4.507

2.  Late-onset hereditary hypophosphatemic rickets with hypercalciuria (HHRH) due to mutation of SLC34A3/NPT2c.

Authors:  Gauri Dhir; Dong Li; Hakon Hakonarson; Michael A Levine
Journal:  Bone       Date:  2016-12-07       Impact factor: 4.398

Review 3.  Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.

Authors:  P Lucato; C Trevisan; B Stubbs; B M Zanforlini; M Solmi; C Luchini; G Girotti; S Pizzato; E Manzato; G Sergi; S Giannini; M Fusaro; N Veronese
Journal:  Osteoporos Int       Date:  2016-06-11       Impact factor: 4.507

4.  Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits.

Authors:  Kathryn M Thrailkill; R Clay Bunn; Sasidhar Uppuganti; Philip Ray; Iuliana Popescu; Evangelia Kalaitzoglou; John L Fowlkes; Jeffry S Nyman
Journal:  Bone       Date:  2020-09-02       Impact factor: 4.398

5.  Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.

Authors:  Elizabeth A Streeten; Amy S Rogstad; Kristin M Flammer; Kiarash Zarbalian; Kathleen Ryan; Mara Horwitz; Michael F Holick; John Shelton
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

6.  Vascular Calcification and Stone Disease: A New Look towards the Mechanism.

Authors:  Allen J Yiu; Daniel Callaghan; Razia Sultana; Bidhan C Bandyopadhyay
Journal:  J Cardiovasc Dev Dis       Date:  2015

7.  Kidney Stones and Risk of Osteoporotic Fracture in Chronic Kidney Disease.

Authors:  Seung Gyu Han; Jieun Oh; Hee Jung Jeon; Chan Park; Jeonghwan Cho; Dong Ho Shin
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

8.  Effects of multi-deficiencies-diet on bone parameters of peripheral bone in ovariectomized mature rat.

Authors:  Thaqif El Khassawna; Wolfgang Böcker; Parameswari Govindarajan; Nathalie Schliefke; Britta Hürter; Marian Kampschulte; Gudrun Schlewitz; Volker Alt; Katrin Susanne Lips; Miriam Faulenbach; Henriette Möllmann; Daniel Zahner; Lutz Dürselen; Anita Ignatius; Natali Bauer; Sabine Wenisch; Alexander Claus Langheinrich; Reinhard Schnettler; Christian Heiss
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

Review 9.  Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review.

Authors:  Matteo Bargagli; Pietro Manuel Ferraro; Matteo Vittori; Gianmarco Lombardi; Giovanni Gambaro; Bhaskar Somani
Journal:  Nutrients       Date:  2021-12-04       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.